Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

@article{Taphoorn2018InfluenceOT,
  title={Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.},
  author={Martin J. B. Taphoorn and Linda Dirven and A A Kanner and Gitit Lavy-Shahaf and Uri Weinberg and Sophie Taillibert and Steven A. Toms and J{\'e}r{\^o}me Honnorat and Thomas C. Chen and Jan Sroubek and Carlos A. David and Ahmed Idbaih and Jacob C. Easaw and Chae-Yong Kim and Jordi Bruna and Andreas F. Hottinger and Yvonne Kew and Patrick Roth and Rajiv Desai and John L Villano and Eilon D. Kirson and Zvi Ram and Roger Stupp},
  journal={JAMA oncology},
  year={2018},
  volume={4 4},
  pages={495-504}
}
Importance Tumor-treating fields (TTFields) therapy improves both progression-free and overall survival in patients with glioblastoma. There is a need to assess the influence of TTFields on patients' health-related quality of life (HRQoL). Objective To examine the association of TTFields therapy with progression-free survival and HRQoL among patients with… CONTINUE READING